MARILENE ALICIA SOUZA
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina
16 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 16
bookPart Amenorreia primária: diagnóstico e tratamento(2016) SOUZA, Marilene Alicia; FONSECA, Angela Maggio da; MASSABKI, Josefina Odete Polak; JúNIOR, José Maria Soares; BARACAT, Edmund ChadabookPart Hiperprolactinemia: diagnóstico e tratamento(2016) HAYASHIDA, Sylvia Asaka Yamashita; FASSOLAS, George; NEVES, Erika Mendonça das; MASSABKI, Josefina Odete Polak; SOUZA, Marilene Alicia; FONSECA, Angela Maggio dabookPart Prevenção e tratamento da osteopenia e osteoporose(2015) FONSECA, Angela Maggio da; BAGNOLI, Vicente Renato; SOUZA, Marilene Alicia; CAVALCANTI, Ana LuciabookPart Amenorreia(2014) SOUZA, Marilene Alicia; FONSECA, Angela Maggio da; BAGNOLI, Vicente Renato; JúNIOR, José Maria Soares; BARACAT, Edmund ChadabookPart Disfunção sexual e climatério(2015) CAVALCANTI, Ana Lucia; PAIXãO, Jucilene Salles da; FONSECA, Angela Maggio da; SOUZA, Marilene Alicia- Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women(2013) FONSECA, Angela Maggio Da; BAGNOLI, Vicente Renato; SOUZA, Marilene Alicia; AZEVEDO, Raymundo Soares; COUTO JUNIOR, Euro De Barros; SOARES JUNIOR, Jose Maria; BARACAT, Edmund ChadaObjective: To assess the relationship of onset of menopause and body mass on the menopausal symptoms in post-menopausal Brazilian women. Design: Observational study conducted by the selection and inclusion of 5968 Brazilian women after menopause. The following variables were analyzed in this study: time at menopause; the relationship between age at menarche and age at menopause; vasomotor symptoms compared with age at the time of menopause and the time of menopause; Kupperman menopausal index (KMI) versus total time of menopause; body mass index (BMI) compared to the time of menopause, vasomotor symptoms, and KMI total score. We used the Chi-square test, and the significance level was set at 5%. Results: The age at natural menopause ranged from 41 to 62 years (mean 48.1 +/- 4.07 years). A younger age at menopause was associated with a high intensity of vasomotor symptoms. These symptoms were more intense in the first 5 years of menopause and decreased with time. The KMI total also decreased with time after menopause, with the exception of arthralgia, myalgia, and insomnia, which did not tend to improve over time. In addition, the vasomotor symptoms and total KMI were more frequent with increasing BMI. Conclusions: Our results suggested that the age of menopause and BMI may influence the intensity of vasomotor symptoms.
bookPart Amenorreia secundária(2015) FONSECA, Angela Maggio da; BAGNOLI, Vicente Renato; ARIE, Wilson Maça Yuki; SOUZA, Marilene AliciabookPart Amenorreia(2013) FONSECA, Angela Maggio da; BAGNOLI, Vicente Renato; SOUSA, Marilene Alicia de; JúNIOR, José Maria Soares; NAVES, Erika Mendonça; BARACAT, Edmund ChadabookPart Tratamento hormonal dos distúrbios sexuais na pós-menopausa(2016) CAVALCANTI, Ana Lucia; SILVA, Jucilene Salles da Paixão; MORAES, Sandra Dircinha Teixeira de Araujo; SOUZA, Marilene Alicia; PEREYRA, Elsa Aida Gay de; BAGNOLI, Vicente Renato- The expression of the estrogen receptor in obese patients with high breast density (HBD)(2014) SOUZA, Marilene Alicia; FONSECA, Angela de Maggio da; BAGNOLI, Vicente Renato; BARROS, Nestor de; NEVES, Erica Mendonca das; MORAES, Sandra Dircinha Teixeira de Araujo; HORTENSE, Victor Hugo Souza; SOARES, Jose Maria; BARACAT, Edmund ChadaObjective: Obesity has been associated with increased risk for breast cancer (BC) mortality. Verifying in women with high breast density (HBD) post-menopausal, the frequency of polymorphisnns of estrogen receptor (ER)alpha-Pvull, ER alpha-Xbal and if they influence the body mass index (BMI). Methods: Study with 308 women with HBD post-menopause divided into two groups according to BMI: 1st group = BMI <25 kg/m(2), 2nd group = BMI >= 25 kg/m(2). It was characterized in the clinical history: menarche, menopause, parity, family history of BC, smoking and alcohol intake. Results: Allele and genotype frequencies for the ER alpha-397-Pvull and ER alpha-351-Xbal: P =43.99%, p =56.01%, pp =32.14%, Pp =47.73%, PP =X =20.13% and X=41.56%, x=58.44%; xx = 33.44%; Xx =50.00%; XX =16.56%, respectively. Both Pvull and Xbal influenced BMI. When Xbal is mutated the tendency is toward higher BMI (0.039), and women with lower BMI were more frequent in Pvull genotype (p = 0.002). More frequent risk factors for BC: menarche before the age of 12 years (35.38%), nulliparity or 1st child after 28 years old (41.66%), family history of BC (19.16%) and overweight/obesity (62.01%). Conclusion: Variations in the ER alpha gene affected the BMI in women with HBD, who already are at increased risk for BC.